Autopsy report · NCT01938664
A Pilot Study of Candesartan as a Treatment for Cocaine Dependence
Cause of deathFutility
“Results of interim efficacy analysis showed results were not promising.”
Life of this trial
- Registered 8 months after it had already started.
- Ran for about 3 years 6 months before it stopped.
- 30 participants enrolled.
- Results were posted on the registry 3 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Baylor College of Medicine
- Sponsor type
- University, hospital or other
- Conditions
- Cocaine Dependence
- Interventions
- Candesartan with CBT; Placebo with CBT
- Participants
- 30
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Hydroxyurea in Primary Progressive Multiple Sclerosis
“No efficacy (interim.analysis)” - LBH589 in Refractory Myelodysplastic Syndromes (MDS)
“Per protocol, the results of a planned interim analysis demonstrated insufficient efficacy and led to early termination of the study.” - A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility
“Lack of efficacy determined at interim analysis” - Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer
“Study was terminated early due to a lack of improved efficacy.” - Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)
“The study was terminated based on the results of a planned interim analysis that showed futility of efficacy.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.